Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia: Results From the CEPHEUS Study in Arabian Gulf Countries

被引：22

作者：

Arafah, Mohamed ^{[1
]}

Al-Hinai, Ali T. ^{[2
]}

Al Mahmeed, Wael ^{[3
]}

Al-Rasadi, Khalid ^{[4
]}

Al Tamimi, Omer ^{[5
]}

Al Herz, Shorook ^{[6
]}

Al Anazi, Faisal ^{[7
]}

Al Nemer, Khalid ^{[8
]}

Metwally, Othman ^{[9
]}

Alkhadra, Akram ^{[10
]}

Fakhry, Mohammed ^{[10
]}

Elghetany, Hossam ^{[11
]}

Medani, Abdel Razak ^{[12
]}

Yusufali, Afzal Hussein ^{[12
]}

Al Jassim, Obaid ^{[12
]}

Al Hallaq, Omar ^{[13
]}

Baslaib, Fahad Omar Ahmed S. ^{[14
]}

Alawadhi, Mahmoud ^{[15
]}

Amin, Haitham ^{[16
]}

Al-Hashmi, Khamis ^{[2
]}

Shehab, Abdullah ^{[17
]}

机构：

[1] King Khalid Univ Hosp, Riyadh 11472, Saudi Arabia

[2] Sultan Qaboos Univ, Coll Med & Hlth Sci, Muscat, Oman

[3] Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates

[4] Sultan Qaboos Univ Hosp, Muscat, Oman

[5] Hamad Med Corp, Doha, Qatar

[6] King Fahad Natl Guard Hosp, Riyadh, Saudi Arabia

[7] Minist Hlth, Riyadh, Saudi Arabia

[8] Secur Force Hosp, Riyadh, Saudi Arabia

[9] King Fahad Gen Hosp, Jeddah, Saudi Arabia

[10] Univ Khobar, King Fahad Hosp, Khobar, Saudi Arabia

[11] Soliman Fakieh Hosp, Jeddah, Saudi Arabia

[12] Dubai Hosp, Dubai, U Arab Emirates

[13] Amer Hosp, Dubai, U Arab Emirates

[14] Rashid Hosp, Dubai, U Arab Emirates

[15] Al Amiri Hosp, Kuwait, Kuwait

[16] Bahrain Def Force Hosp, Riffa, Bahrain

[17] UAE Univ, Al Ain, U Arab Emirates

来源：

ANGIOLOGY | 2014年 / 65卷 / 10期

关键词：

hypercholesterolemia; lipids; low-density lipoprotein; cardiovascular; coronary; guidelines; Arabian Gulf countries; DENSITY-LIPOPROTEIN-CHOLESTEROL; CARDIOVASCULAR-DISEASE PREVENTION; CORONARY-HEART-DISEASE; LIPID-LOWERING-THERAPY; CLINICAL-PRACTICE; EUROPEAN GUIDELINES; MYOCARDIAL-INFARCTION; EVENTS; MEN; PRAVASTATIN;

D O I：

10.1177/0003319713512414

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

The Centralized pan-Middle East Survey on the undertreatment of hypercholesterolemia (CEPHEUS) survey evaluated the attainment of low-density lipoprotein cholesterol (LDL-C) goals among patients on lipid-lowering drugs (LLDs) according to the updated National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP-III) guideline. The survey was conducted in 6 Arabian Gulf countries. Patients aged >= 18 years on LLDs for at least >= 3 months (stable medication for >= 6 weeks) were recruited. Fasting blood samples were collected at a single visit. In this survey, 5276 (58.2% male) patients were included in the final analysis. The LDL-C goal was attained in 91.1% of low-risk, 52.7% of high-risk, and 32.0% in very-high-risk categories. Goal attainment was directly related to female gender, age < 40 years, history of diabetes, and family history of cardiovascular disease. The results of this survey highlight the suboptimal management of hypercholesterolemia across Arabian Gulf countries.

引用

页码：919 / 926

页数：8

共 34 条

[1] Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
Alberti, K. G. M. M.
Eckel, Robert H.
Grundy, Scott M.
Zimmet, Paul Z.
Cleeman, James I.
Donato, Karen A.
Fruchart, Jean-Charles
James, W. Philip T.
Loria, Catherine M.
Smith, Sidney C., Jr.
[J]. CIRCULATION, 2009, 120 (16) : 1640 - 1645
[2] [Anonymous], 1996, EUR HEART J, V17, P163
[3] Cardiovascular morbidity associated with nonadherence to statin therapy
Blackburn, DE
Dobson, RT
Blackburn, JL
Wilson, TW
[J]. PHARMACOTHERAPY, 2005, 25 (08): : 1035 - 1043
[4] Physician follow-up and provider continuity are associated with long-term medication adherence - A study of the dynamics of statin use
Brookhart, M. Alan
Patrick, Amanda R.
Schneeweiss, Sebastian
Avorn, Jerry
Dormuth, Colin
Shrank, William
van Wijk, Boris L. G.
Cadarette, Suzanne M.
Canning, Claire F.
Solomon, Daniel H.
[J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (08) : 847 - 852
[5] Undertreatment of hypercholesterolemia
Daskalopoulou, Stella S.
Doonan, Robert J.
Mikhailidis, Dimitri P.
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (02) : 439 - 443
[6] European guidelines on cardiovascular disease prevention in clinical practice -: Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice
De Backer, G
Ambrosioni, E
Borch-Johnsen, K
Brotons, C
Cifkova, R
Dallongeville, J
Ebrahim, S
Faergeman, O
Graham, I
Mancia, G
Cats, VM
Orth-Gomér, K
Perk, J
Pyörälä, K
Rodicio, JL
Sans, S
Sansoy, V
Sechtem, U
Silber, S
Thomsen, T
Wood, D
[J]. EUROPEAN HEART JOURNAL, 2003, 24 (17) : 1601 - 1610
[7] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS
Downs, JR
Clearfield, M
Weis, S
Whitney, E
Shapiro, DR
Beere, PA
Langendorfer, A
Stein, EA
Kruyer, W
Gotto, AM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20): : 1615 - 1622
[8] Centralized Pan-European Survey on the Undertreatment of Hypercholesterolemia in Patients Using Lipid Lowering Drugs-The CEPHEUS-Greece Survey
Elisaf, Moses S.
Nikas, Nikos
[J]. ANGIOLOGY, 2010, 61 (05) : 465 - 474
[9] EUROASPIRE II Study Group Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries, 2001, EUR HEART J, V22, P554
[10] Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults - Findings from the National Health and Nutrition Examination Survey, 1999 to 2000
Ford, ES
Mokdad, AH
Giles, WH
Mensah, GA
[J]. CIRCULATION, 2003, 107 (17) : 2185 - 2189

← 1 2 3 4 →